İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2021

Effects of cannabinoid receptor 2 synthetic agonist, AM1241, on bleomycin induced pulmonary fibrosis

Dergi

BIOTECHNIC HISTOCHEMISTRY

ISSN 1052-0295

ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.

YÖKSİS OpenAlex SJR Q3 JCR Q4 Atıf 21 Yüzdelik 76.9% FWCI 0.88
Yıl
2021
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • YÖKSİS dergi adı BIOTECHNIC HISTOCHEMISTRY
  • Katalog eşleşmesi (ISSN) Biotechnic and Histochemistry
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex · İngilizce

Bleomycin (BLM) is a chemotherapeutic agent that can cause pulmonary fibrosis. Little is known about the possible protective role of the CB2 receptor agonist, AM1241. We investigated the effects of CB2 receptor activation by AM1241 on BLM induced lung fibrosis in a rat model. BLM was administered via the trachea. Adult female Wistar rats were divided into five groups: saline (control group), BLM (BLM group), CB2 agonist (AM1241) + BLM (BLMA group), CB2 antagonist (AM630) and CB2 agonist (AM1241) + BLM (BLMA + A group), and vehicle (dimethylsulfoxide) + BLM (BLM + vehicle group). Hydroxyproline, collagen type 1, total protein, glutathione (GSH), malondialdehyde (MDA), interleukin (IL)-6 and tumor necrosis factor (TNF)-α levels were measured in lung fibrosis and control tissue using standard methods. We investigated the histopathology of lung tissue to determine the extent of fibrosis. We found significantly higher levels of hydroxyproline, TNF-α, IL-6 and total protein in the BLM group compared to the BLMA group. The level of GSH also was higher in the BLMA group compared to the BLM group. Inflammation and fibrotic changes were significantly reduced in the BLMA group. Our findings suggest that CB2 receptor activation provided protection against BLM induced pulmonary fibrosis by suppressing oxidative stress and increasing cytokines.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

21 atıf

OpenAlex cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 13 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. Therapeutic use of fisetin and pirfenidone combination in bleomycin-induced pulmonary fibrosis in adult male albino rats 2025 Atıf 4 · OpenAlex
  2. Therapeutic use of fisetin and pirfenidone combination in bleomycin-induced pulmonary fibrosis in adult male albino rats 2025 Atıf 4 · OpenAlex
  3. Therapeutic use of fisetin and pirfenidone combination in bleomycin-induced pulmonary fibrosis in adult male albino rats 2025 Atıf 4 · OpenAlex
  4. Therapeutic use of fisetin and pirfenidone combination in bleomycin‑induced pulmonary fibrosis in adult male albino rats 2025 Atıf 4 · OpenAlex
  5. Therapeutic use of fisetin and pirfenidone combination in bleomycin-induced pulmonary fibrosis in adult male albino rats 2025 Atıf 4 · OpenAlex
  6. An evaluation of the effects of glabridin and dexamethasone in bleomycin-induced pulmonary fibrosis: The role of BKCa channels 2023 Atıf 4 · OpenAlex
  7. An evaluation of the effects of glabridin and dexamethasone in bleomycin-induced pulmonary fibrosis: The role of BKCa channels 2023 Atıf 3 · OpenAlex
  8. Cannabinoid receptor ligands modulate fibrosis and inflammation in idiopathicpulmonary fibrosis: a preliminary study 2024 Atıf 2 · OpenAlex
  9. Cannabinoid receptor ligands modulate fibrosis and inflammation in idiopathic pulmonary fibrosis: a preliminary study 2024 Atıf 2 · OpenAlex
  10. Antifibrotic Effects of Thymus syriacus Essential Oil in Bleomycin-Induced Pulmonary Fibrosis via Suppression of the TGF-β1/Smad2 Axis 2026 Atıf 1 · OpenAlex

Yazarlar

  1. ALİ PARLAR
  2. SEYFULLAH OKTAY ARSLAN ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ
  3. ÖNDER YUMRUTAŞ ADIYAMAN ÜNİVERSİTESİ
  4. EBRU ANNAÇ
  5. ALPER YALÇIN
  6. FATİH ÜÇKARDEŞ
  7. HASAN AYDIN
  8. MUHAMMED FATİH DOĞAN
  9. ELİF KAYHAN
  10. MEHMET KAYA ÖZER ADIYAMAN ÜNİVERSİTESİ